Selected article for: "Dengue virus and Vaccinia virus"
Author: Amara, Ali; Mercer, Jason
Title: Viral apoptotic mimicry
  • Cord-id: rzd6utbb
  • Document date: 2015_6_8
    • ID: rzd6utbb
    Snippet: As opportunistic pathogens, viruses have evolved many elegant strategies to manipulate host cells for infectious entry and replication. Viral apoptotic mimicry, defined by the exposure of phosphatidylserine — a marker for apoptosis — on the pathogen surface, is emerging as a common theme used by enveloped viruses to promote infection. Focusing on the four best described examples (vaccinia virus, dengue virus, Ebola virus and pseudotyped lentivirus), we summarize our current understanding of
    Document: As opportunistic pathogens, viruses have evolved many elegant strategies to manipulate host cells for infectious entry and replication. Viral apoptotic mimicry, defined by the exposure of phosphatidylserine — a marker for apoptosis — on the pathogen surface, is emerging as a common theme used by enveloped viruses to promote infection. Focusing on the four best described examples (vaccinia virus, dengue virus, Ebola virus and pseudotyped lentivirus), we summarize our current understanding of apoptotic mimicry as a mechanism for virus entry, binding and immune evasion. We also describe recent examples of non-enveloped viruses that use this mimicry strategy, and discuss future directions and how viral apoptotic mimicry could be targeted therapeutically. SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nrmicro3469) contains supplementary material, which is available to authorized users.

    Search related documents:
    Co phrase search for related documents
    • activator signal transducer and adaptive immunity: 1, 2
    • active process and acute sars cov respiratory syndrome coronavirus: 1, 2
    • active process and adaptive immunity: 1
    • acute sars cov respiratory syndrome coronavirus and adaptive advantage: 1
    • acute sars cov respiratory syndrome coronavirus and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars cov respiratory syndrome coronavirus and additional membrane: 1, 2, 3
    • acute sars cov respiratory syndrome coronavirus and additional step: 1, 2, 3
    • acute sars cov respiratory syndrome coronavirus and additional study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • adaptive immunity and additional study: 1